Futura Medical (LON:FUM) Trading 10.3% Higher – Should You Buy?

Futura Medical plc (LON:FUM) shares rose 10.3% during mid-day trading on Friday . The stock traded as high as GBX 0.42 and last traded at GBX 0.42. 3,594,404 shares traded hands during trading, a decline of 63% from the average session volume of 9,689,350 shares. The stock had previously closed at GBX 0.38.

Futura Medical Stock Performance

The company has a market capitalization of £2.43 million, a price-to-earnings ratio of -0.15 and a beta of 0.02. The company has a fifty day simple moving average of GBX 0.53 and a two-hundred day simple moving average of GBX 0.94.

Futura Medical (LON:FUM) last posted its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. The business had revenue of GBX 170 million for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. As a group, analysts expect that Futura Medical plc will post 2.8486672 EPS for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.